Zim Laboratories Limited is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The company also has wholly owned subsidiaries present overseas which are engaged in the manufacturing & wholesale of pharmaceutical products, market research and research & development activities.
Financial Results:
Zim Laboratories Ltd reported Revenues for Q1FY24 of ₹67.44 Crores down from ₹92.75 Crore year on year, a fall of 27.29%.
Total Expenses for Q1FY24 of ₹68.38 Crores down from ₹87.16 Crores year on year, a fall of 21.55%.
Consolidated Net Profit of ₹0.23 Crores down 95.53% from ₹5.15 Crores in the same quarter of the previous year.
The Earnings per Share is ₹0.05, down 95.28% from ₹1.06 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.